Oli Denne

Cambridge UK

Contact Me Today

+44 1223 446 400

Email me Call me

Oli is a senior associate in our Cambridge office and is part of the Corporate Technology team.

Oli advises a range of companies in the tech and life sciences sectors on a variety of corporate matters, including venture capital investments, fundraisings, M&A and joint ventures.

CV

Since 2023 Senior Associate, Taylor Wessing

2021 - 2023 Associate, Taylor Wessing

2019 - 2020 Associate, Slaughter and May

Career

Since 2023 Senior Associate, Taylor Wessing

2021 - 2023 Associate, Taylor Wessing

2019 - 2020 Associate, Slaughter and May

Education

2019 Admitted as a solicitor in England & Wales

2016 - 2017 GDL & LPC, BPP Law School

2012 - 2015 BA Politics, University of Warwick

Experience

Apollo Therapeutics closes $226.5 million series C financing

We advised Apollo Therapeutics in their USD226.5 million series C fundraising. Apollo aims to advance pipeline programs through clinical development and further fund the company’s drug discovery and development activities based on breakthroughs in basic medical research made at its partner institutions, which include The Institute of Cancer Research.

Press release

Oli's news & insights

View Oli's insights

Click here to find out more

Corporate/M&A & capital markets

Shift Bioscience raises US$16 million seed funding

21 October 2024

by Ross McNaughton and Oli Denne

Corporate/M&A & capital markets

Advising Nuclera on its US$75 million series C financing

16 October 2024

by multiple authors

Click here to find out more

Corporate/M&A & capital markets

Advising Healx on its $47 million Series C funding

20 August 2024

by multiple authors

Click here to find out more